Abstract
Increasing evidence indicated that tripartite motif containing 37 (TRIM37) was involved in the tumorigenesis of several cancer types. However, its expression pattern and biological functions in pancreatic ductal adenocarcinoma (PDAC) remained unknown. In this study, real-time PCR, Western blot and immunohistochemistry was performed to examine the expression of TRIM37 in the pancreatic cancerous tissues. Colony formation assay and cell migration assay were performed to study the functions of TRIM37 in pancreatic cancer cells. Dual-luciferase assay was performed to study the regulation of TRIM37 on beta-catenin/TCF signaling. It was found that the expression level of TRIM37 was significantly higher in pancreatic cancerous tissues compared with the adjacent normal tissues. Function analysis indicated that overexpression of TRIM37 promoted the growth and migration of the pancreatic cancer cells, while knocking down the expression of TRIM37 inhibited the growth and migration of the pancreatic cancer cells. The molecular mechanism study suggested that TRIM37 interacted with beta-catenin and activated the transcriptional activity of beta-catenin/TCF complex as well as the expression of its downstream target genes. Taken together, our study showed the oncogenic roles of TRIM37 in pancreatic cancer, and TRIM37 might be a promising target for pancreatic cancer treatment.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
Liang C, Wang Z, Li YY, Yu BH, Zhang F, Li HY. Mir-33a suppresses the nuclear translocation of beta-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells. Tumour Biol. (ahead of print). 2015.
Jiang S, Zhu L, Tang H, et al. Ape1 regulates wnt/beta-catenin signaling through its redox functional domain in pancreatic cancer cells. Int J Oncol. (ahead of print). 2015.
Chen X, Liu X, Lang H, Zhang S, Luo Y, Zhang J. S100 calcium-binding protein a6 promotes epithelial-mesenchymal transition through beta-catenin in pancreatic cancer cell line. PLoS One. 2015;10:e0121319.
Kumaran S, Samantha KS, Halagowder D. Does beta-catenin cross-regulate NFkappaB signalling in pancreatic cancer and chronic pancreatitis? Pathobiology. 2015;82:28–35.
Xu W, Wang Z, Zhang W, et al. Mutated k-ras activates cdk8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the wnt/beta-catenin signaling pathway. Cancer Lett. 2015;356:613–27.
Macdonald BT, Semenov MV, He X. Snapshot: Wnt/beta-catenin signaling. Cell. 2007;131:1204.
Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149:1192–205.
Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127:469–80.
Kallijarvi J, Lahtinen U, Hamalainen R, Lipsanen-Nyman M, Palvimo JJ, Lehesjoki AE. Trim37 defective in mulibrey nanism is a novel ring finger ubiquitin e3 ligase. Exp Cell Res. 2005;308:146–55.
Bhatnagar S, Gazin C, Chamberlain L, et al. Trim37 is a new histone h2a ubiquitin ligase and breast cancer oncoprotein. Nature. 2015;516:116–20.
Dimova I, Orsetti B, Negre V, et al. Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array cgh analysis. Tumori. 2009;95:357–66.
Karlberg S, Lipsanen-Nyman M, Lassus H, Kallijarvi J, Lehesjoki AE, Butzow R. Gynecological tumors in mulibrey nanism and role for ring finger protein trim37 in the pathogenesis of ovarian fibrothecomas. Mod Pathol. 2009;22:570–8.
Brodtkorb M, Lingjaerde OC, Huse K, Troen G, et al. Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma. Blood. 2014;123:1051–4.
Balestra FR, Strnad P, Fluckiger I, Gonczy P. Discovering regulators of centriole biogenesis through siRNA-based functional genomics in human cells. Dev Cell. 2013;25:555–71.
Tuna M, Smid M, Martens JW, Foekens JA. Prognostic value of acquired uniparental disomy (aupd) in primary breast cancer. Breast Cancer Res Treat. 2012;132:189–96.
Hamalainen RH, Mowat D, Gabbett MT, O’Brien TA, Kallijarvi J, Lehesjoki AE. Wilms’ tumor and novel trim37 mutations in an Australian patient with mulibrey nanism. Clin Genet. 2006;70:473–9.
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Figure S1
The expression of TRIM37 did not affect the expression of Wnt 3a. BXPC3 and Suit2 cells were overexpressed TRIM37 or knocked down the expression of TRIM37, and the mRNA level of Wnt3a was examined using qPCR. (JPEG 837 kb)
Rights and permissions
About this article
Cite this article
Jiang, J., Tian, S., Yu, C. et al. TRIM37 promoted the growth and migration of the pancreatic cancer cells. Tumor Biol. 37, 2629–2634 (2016). https://doi.org/10.1007/s13277-015-4078-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-015-4078-7